News Sentiment

MGX sentiment intelligence

Metagenomi, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.24 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 42

directly relevant articles

Source quality 5

high-authority source matches

Trend context Trend inactive

-2.4% over one week, +3.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Metagenomi Therapeutics (MGX) Edges Higher as Stock Tests Key Resistance Near $1.41 - Small Cap Breakouts

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction -2.4% Price reacting lower
Trend fit Trend inactive 3.3% over four weeks
Fair value -60.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 31
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 42
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
TradingView 7
Stock Titan 4
Barron's 4
simplywall.st 3
Investing.com Nigeria 2
Investing.com 2
eciks.org 2

Event Lens

What the news is about

Classified themes
Market update 26
Earnings 18
Analyst action 3
Regulatory and legal 1
Capital return 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-50 of 50